Hyperthyroidism medications

24,470views

Hyperthyroidism medications

FINAL

FINAL

ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Acyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Cardiac tamponade
Endocarditis
Myocarditis
Rheumatic heart disease
Heart failure
Cor pulmonale
Long QT syndrome and Torsade de pointes
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Atrial flutter
Premature atrial contraction
Atrial fibrillation
Atrioventricular nodal reentrant tachycardia (AVNRT)
Deep vein thrombosis
Hypotension
Orthostatic hypotension
Polycystic kidney disease
Pheochromocytoma
Cushing syndrome
Renal artery stenosis
Hypertension
Aneurysms
Aortic dissection
Peripheral artery disease
Angina pectoris
Unstable angina
Prinzmetal angina
Myocardial infarction
Stable angina
Arterial disease
ECG normal sinus rhythm
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
ECG basics
ECG intervals
ECG axis
ECG QRS transition
ECG rate and rhythm
Cardiac conduction system
Cardiac conduction velocity
Normal heart sounds
Abnormal heart sounds
Cardiovascular changes during postural change
Cardiovascular changes during hemorrhage
Cardiac preload
Cardiac contractility
Cardiac afterload
Measuring cardiac output (Fick principle)
Thrombocytopenia: Clinical
Heparin-induced thrombocytopenia
Immune thrombocytopenia
Gout
Chronic kidney disease: Clinical
Traumatic brain injury: Pathology review
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Blood groups and transfusions
Blood products and transfusion: Clinical
HIV (AIDS)
Hodgkin lymphoma
Acromegaly
Musculoskeletal injuries: Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Diabetes insipidus
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetes insipidus: Nursing process (ADPIE)
Managing diabetes during the holidays: Information for patients and families
Hypoglycemics: Insulin secretagogues
Insulins
Epistaxis: Nursing process (ADPIE)
Appendicitis
Appendicitis: Clinical
Appendicitis: Pathology review
Appendicitis: Nursing process (ADPIE)
Hypothyroidism medications
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Sympathomimetics: Direct agonists
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Conjunctivitis: Nursing process (ADPIE)
Stroke: Clinical
Stroke: Nursing process (ADPIE)
Peptic ulcer
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Peptic ulcers and stomach cancer: Clinical
Gallbladder histology
Gallbladder disorders: Clinical
Acute cholecystitis
Oral cancer
Hepatitis A and Hepatitis E virus
Viral hepatitis: Clinical
Hepatitis medications
Seizures: Pathology review
Seizures: Clinical
Seizures and epilepsy
Febrile seizure
Seizure disorder: Nursing process (ADPIE)
Non-urothelial bladder cancers
Inflammatory bowel disease: Clinical
Inflammatory bowel disease: Pathology review
Anticoagulants: Heparin
Postoperative evaluation: Clinical
Trigeminal neuralgia
Trigeminal neuralgia: Nursing process (ADPIE)
Hypoparathyroidism
Pancreatitis: Pathology review
Pancreatitis: Clinical
Acute pancreatitis
Pancreatitis: Nursing process (ADPIE)
Chronic pancreatitis
Sickle cell disease (NORD)
Sickle cell disease: Clinical
Sickle cell disease: Nursing process (ADPIE)
Class IV antiarrhythmics: Calcium channel blockers and others
Hypertension: Clinical
Pulmonary hypertension
Hypertension: Nursing process (ADPIE)
Osteoarthritis
Joint pain: Clinical
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Hyperthyroidism
Hyperthyroidism medications
Hyperthyroidism: Nursing process (ADPIE)

Transcript

Watch video only

In hyperthyroidism, ‘hyper’ refers to having too much, and ‘thyroid’ refers to thyroid hormones, so hyperthyroidism refers to a condition where there’s excess thyroid hormones.

Medications used to treat hyperthyroidism either reduce the level of thyroid hormones or treat the symptoms by targeting the affected tissue.

There are 2 different thyroid hormones; triiodothyronine or T3, and thyroxine or T4.

Now, if we zoom into the thyroid gland, we’ll find thousands of follicles, which are small, hollow spheres whose walls are lined with follicular cells, or thyrocytes.

Zooming further into these follicular cells, we’ll see their apical side that surrounds a central lumen filled with a viscous fluid called the colloid.

The colloid contains the precursor hormone thyroglobulin.

The basolateral side of follicular cells is in contact with blood vessels that supply these cells.

Synthesis of thyroid hormones begins when follicular cells take in inorganic iodide ions from the blood, along with two sodium ions, via a sodium- iodide symporter.

This step is known as ‘iodide trap’.

The iodide ion is pumped via the pendrin protein, into the viscous fluid inside the follicle called the colloid, which contains thyroglobulin; the precursor of thyroid hormone.

In the colloid, inorganic iodide undergoes oxidation via the enzyme thyroid peroxidase or TPO, to become organic iodide, which then binds to the tyrosine in thyroglobulin.

This step is known as iodination.

Some tyrosine residues bind to only one iodine and form monoiodotyrosine or MIT, whereas others bind to two iodine atoms to form diiodotyrosine or DIT.

These molecules are then coupled together by the same enzyme thyroid peroxidase.

This process is known as coupling.

Coupling one MIT with one DIT creates T3, while coupling 2 DIT molecules creates T4.

T4 is generally created in greater amounts than T3, with T3 being the more active form with a half life of 1 to 2 days, while T4 is less active but has a longer half life of 6 to 8 days.

Once released from the thyroid gland, most of the T3 and T4 travels via the blood by binding with the thyroxine - binding globulin, or TBG, to reach the target cell.

Alternatively, small amounts of T3 and T4 stay unbound, and therefore they are referred to as “free” thyroid hormones.

Only “free” thyroid hormones are physiologically active because they are able to enter the cell.

Now, once inside the cell, T4 is mostly converted into T3 by the enzyme 5’- deiodinase. T3 binds to thyroid hormone receptors which are within the cell’s nucleus, and these receptors regulate gene expression, which ultimately lead to various metabolic and physiologic effects in the body.

This increase in metabolism uses up sugars and fats for energy and produces more body heat.

Thyroid hormones also help activate the sympathetic nervous system which is responsible for the fight or flight response.

This increases heart rate and cardiac output, respiratory rate, and mental alertness.

Thyroid hormones also increase the gastrointestinal or GI motility and they are necessary for normal neuronal development in growing fetuses and young children.

Now, hyperthyroidism can happen in a few different ways.

The most common cause is Graves’ disease, an autoimmune disorder where B cells produce autoantibodies against thyroid stimulating hormone receptors on follicular cells.

These autoantibodies bind to the receptors and activate them, which causes the thyroid follicles to grow and produce more thyroid hormones.

One complication is Graves’ ophthalmopathy which is inflammation and edema in the tissue around the eyes, causing the eyeball to be displaced forwards, eyelids to retract and giving the eyes a “bulgingappearance.

Other disorders like toxic multinodular goiter and thyroiditis can also cause increased release of thyroid hormones.

Now, the symptoms of hyperthyroidism include weight loss despite an increase in appetite because of the higher basal metabolic rate; heat intolerance because the body is producing more heat; and rapid heart rate or tachycardia, sweating, hyperactivity, anxiety and insomnia because of the effect of thyroid hormones on the sympathetic nervous system.

Untreated hyperthyroidism combined with a stressor like an infection or illness can trigger a life- threatening complication called thyroid storm.

Many of the symptoms of hyperthyroidism then become exaggerated, leading to severe tachyarrhythmia, high fever, delirium, and coma.

Now, there are several classes of medications to control hyperthyroidism.

First, we can target the thyroid gland itself, and either decrease the synthesis of thyroid hormones or prevent them from being released.

The other option, at the target tissue peripherally; is to decrease the effectiveness of the thyroid hormones; this only manages the symptoms but doesn’t treat the cause.

Let’s start with the radioactive iodine therapy, also known as “radioiodine ablation therapy”.

The isotope of iodine that is used is I131 .

It’s taken peroral and eventually gets taken up by the thyroid.

Over the course of a few weeks, the radioactive isotope collects in the colloid and emits beta radiation that causes permanent damage to the thyroid.

This is the definitive treatment for hyperthyroidism caused by Graves’ disease and toxic multinodular goiter, but it could also worsen Graves’ ophthalmopathy.

Since the thyroid is permanently destroyed, the person will need to take thyroid hormone replacements like levothyroxine to prevent hypothyroidism.

Radioactive iodine crosses the placenta and is secreted in breast milk, so it should be avoided in people who are pregnant or breastfeeding.

Therefore, administration of radioactive iodine to childbearing individuals requires a negative pregnancy test!

Finally, as far as side effects go, radioactive iodide can cause infertility, thyroiditis, and radiation toxicity, such as neoplasia, hematopoietic suppression, and salivary and lacrimal toxicity.

Next, we have thioamides, which include propylthiouracil, or PTU, and methIMAzole.

Both of these medications are given perorally and are absorbed by the thyroid where they inhibit thyroid peroxidase.

This stops the oxidation of iodide ions into organic iodine, the iodination of tyrosine residues in thyroglobulin, and the coupling of MIT and DIT to form T3 and T4.

It’s important to note that these medications do not inhibit the release of thyroid hormones; therefore they require several weeks until the thyroid depletes its storage of hormones to manifest their therapeutic effect.

In addition, PTU also works in the peripheral tissue by inhibiting 5’- deiodinase to block the conversion of T4 into T3, which makes it the preferred medication during thyroid storms.

Key Takeaways

Hyperthyroidism refers to a condition in which there is excess thyroid hormones. Medications used to treat hyperthyroidism aim at reducing the level of thyroid hormones or the management of associated symptoms. Hyperthyroidism medications include beta blockers, radioactive iodine, propylthiouracil, methimazole, Lugol's iodine, propranolol, and corticosteroids.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Hyperthyroidism: Diagnosis and Treatment" Am Fam Physician (2016)
  5. "Subclinical Hyperthyroidism: When to Consider Treatment" Am Fam Physician (2017)
  6. "Hyperthyroidism" The Lancet (2016)
  7. "THE EFFECT OFD- VERSUSL- PROPRANOLOL IN THE TREATMENT OF HYPERTHYROIDISM" Clinical Endocrinology (1990)
  8. "Increased cancer incidence after radioiodine treatment for hyperthyroidism" Cancer (2007)
  9. "Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease" Endocrine (2017)